Spots Global Cancer Trial Database for A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Elotuzumab in Combination With Pomalidomide and Low Dose Dexamethasone and Elotuzumab in Combination With Nivolumab in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.
Official Title: A Phase 2, Multiple Cohort Study of Elotuzumab in Combination With Pomalidomide and Low-Dose Dexamethasone (EPd), and in Combination With Nivolumab (EN), in Patients With Multiple Myeloma Relapsed or Refractory to Prior Treatment With Lenalidomide.
Study ID: NCT02612779
Conditions
Study Description
Brief Summary: Study of elotuzumab in combination with pomalidomide and low dose dexamethasone (EPd Cohort) and elotuzumab in combination with nivolumab (EN Cohort) to assess the safety and efficacy of these combination therapies for treatment of relapsed or refractory MM patients.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Southern Cancer Center, Mobile, Alabama, United States
Sansum Clinic - USOR, Santa Barbara, California, United States
Colorado Blood Cancer Institute - PPDS, Denver, Colorado, United States
Rocky Mountain Cancer Centers (Williams) - USOR, Denver, Colorado, United States
Florida Cancer Specialists - EAST - SCRI - PPDS, Saint Petersburg, Florida, United States
Florida Cancer Specialists - NORTH - SCRI - PPDS, Saint Petersburg, Florida, United States
Illinois Cancer Care, Peoria, Illinois, United States
American Oncology Partners of Maryland, PA, Bethesda, Maryland, United States
Bay Hematology Oncology, Easton, Maryland, United States
University of Michigan, Ann Arbor, Michigan, United States
Barbara Ann Karmanos Cancer Center, Detroit, Michigan, United States
Washington University, Saint Louis, Missouri, United States
Mount Sinai Medical Center, New York, New York, United States
Greenville Health System, Greenville, South Carolina, United States
Avera Health Care, Sioux Falls, South Dakota, United States
Jones Clinic PC, Germantown, Tennessee, United States
Tennessee Oncology NASH - SCRI - PPDS, Nashville, Tennessee, United States
Texas Oncology (Loop) - USOR, San Antonio, Texas, United States
Virginia Cancer Specialists (Leesburg) - USOR, Leesburg, Virginia, United States
Swedish Medical Center, Seattle, Washington, United States
Cancer Care Northwest, Spokane Valley, Washington, United States
Aurora Health Care, Burlington, Wisconsin, United States
Contact Details
Name: Bristol Myers Squibb
Affiliation: Bristol-Myers Squibb
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
